K-CONNECT SUMMIT 2026, co-hosted by Gene Solutions, the Vietnam Institute of Clinical Medicine and Pharmacy, and the Vietnam Medical Association, will convene oncologists, healthcare professionals, researchers, and international experts to advance scientific exchange in early cancer detection and precision oncology.
Following the success of K-CONNECT APAC 2025, which brought together more than 100 oncologists and molecular experts from nine Asia-Pacific countries, this year’s summit builds on the strong foundation established around circulating tumor DNA (ctDNA), molecular residual disease (MRD) monitoring, and comprehensive genomic profiling (CGP) in precision oncology.
K-CONNECT SUMMIT 2026 will expand the conversation toward a broader and more integrated view of cancer care — where artificial intelligence (AI) and multi-omics are increasingly shaping discussions around earlier detection, longitudinal disease monitoring and treatment decision-making.
Held under the theme “AI & Multi-Omics – Shifting Paradigms in the New Era of Early Cancer Detection and Precision Oncology,” this year’s summit is expected to convene more than 20 leading faculty members from renowned institutions across Asia-Pacific and approximately 1,000 oncologists and healthcare professionals from 10 countries, reflecting the growing regional interest in advanced molecular technologies and their responsible integration into oncology care. 
The program will feature three main scientific sessions:
Session 1: Early Cancer Detection
Exploring the role of ctDNA and AI in modern cancer screening, including clinical evidence, high-risk population strategies, multi-cancer screening, and health economic perspectives.
Session 2: Evidence and Clinical Validity
Discussing global trends in cancer management, with a focus on ctDNA monitoring, CGP, CGTP, multi-omics, and clinical case applications across solid tumors.
Session 3: Precision Oncology in Practice and Future Directions
Addressing practical considerations for implementing precision oncology in clinical settings — from data interpretation and treatment selection to follow-up strategies and future directions.
K-CONNECT SUMMIT 2026 is part of the broader K-CONNECT Platform, an initiative developed by Gene Solutions to connect international experts across the oncology community. The platform aims to advance knowledge exchange, strengthen research collaboration, and support the responsible translation of emerging technologies into clinical applications.
Through K-CONNECT SUMMIT 2026, Gene Solutions and its co-hosting partners continue to support a connected international ecosystem where oncologists, healthcare practitioners, researchers, and industry partners can exchange insights, share clinical experience, and explore how innovation can be thoughtfully applied to improve cancer care.
Event Details
📅 Date: Saturday, May 9, 2026
🕘 Time: 09:00 – 15:25 GMT+7
💻 Format: Virtual
👉 Register for K-CONNECT SUMMIT 2026: HERE
👉 Learn more:
https://kconnect.genesolutions.com/event/k-connect-summit-2026/
